Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sentinel node dissection is safe in the treatment of early-stage vulvar cancer.
Van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, Maggioni A, Gaarenstroom KN, Baldwin PJ, Van Dorst EB, Van der Velden J, Hermans RH, van der Putten H, Drouin P, Schneider A, Sluiter WJ. Van der Zee AG, et al. Among authors: van dorst eb, van der velden j, van der putten h. J Clin Oncol. 2008 Feb 20;26(6):884-9. doi: 10.1200/JCO.2007.14.0566. J Clin Oncol. 2008. PMID: 18281661 Free article. Clinical Trial.
Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience.
Nomden CN, de Leeuw AA, Roesink JM, Tersteeg RJ, Moerland MA, Witteveen PO, Schreuder HW, van Dorst EB, Jürgenliemk-Schulz IM. Nomden CN, et al. Among authors: van dorst eb. Radiother Oncol. 2013 Apr;107(1):69-74. doi: 10.1016/j.radonc.2013.04.006. Epub 2013 Apr 29. Radiother Oncol. 2013. PMID: 23639580
Effect of surgical volume on short-term outcomes of cytoreductive surgery for advanced-stage ovarian cancer: A population-based study from the Dutch Gynecological Oncology Audit.
Algera MD, van Driel WJ, Slangen BFM, Wouters MWJM, Kruitwagen RFPM; participants of the Dutch Gynecological Oncology Audit Collaborator Group. Algera MD, et al. Gynecol Oncol. 2024 Apr 29;186:144-153. doi: 10.1016/j.ygyno.2024.04.002. Online ahead of print. Gynecol Oncol. 2024. PMID: 38688188 Free article.
Incidence of inguinofemoral lymph node metastases at the first local recurrence of vulvar cancer: a Dutch nationwide study.
Pleunis N, Pouwer AW, Oonk MHM, van Doorn HC, Tjiong MY, van der Velden J, Zijlmans H, van Poelgeest MIE, van Dorst EB, Slangen BFM, Verhoef LCG, Pijnenborg JMA, de Hullu JA. Pleunis N, et al. Among authors: van dorst eb. Br J Cancer. 2023 Oct;129(6):956-964. doi: 10.1038/s41416-023-02373-0. Epub 2023 Jul 28. Br J Cancer. 2023. PMID: 37507545
Urinary incontinence more than 15 years after premenopausal risk-reducing salpingo-oophorectomy: a multicentre cross-sectional study.
Terra L, Heemskerk-Gerritsen BAM, Beekman MJ, Engelhardt E, Mourits MJE, van Doorn HC, de Hullu JA, Mom CH, Slangen BFM, Gaarenstroom KN, van Beurden M, Roeters Van Lennep JE, van Dorst EBL, van der Kolk LE, Collée JM, Wevers MR, Ausems MGEM, van Engelen K, van de Beek I, Berger LPV, van Asperen CJ, Gomez Garcia EB, Maas AHEM, Hooning MJ, Steensma AB, van Leeuwen FE. Terra L, et al. Among authors: van dorst ebl. BJOG. 2024 Jan;131(1):99-108. doi: 10.1111/1471-0528.17591. Epub 2023 Jul 2. BJOG. 2024. PMID: 37394722
Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on cognition in women with high familial risk of ovarian cancer: A cross-sectional study.
Terra L, Lee Meeuw Kjoe PR, Agelink van Rentergem JA, Beekman MJ, Heemskerk-Gerritsen BAM, van Beurden M, Roeters van Lennep JE, van Doorn HC, de Hullu JA, Mourits MJE, van Dorst EBL, Mom CH, Slangen BFM, Gaarenstroom KN, van der Kolk LE, Collée JM, Wevers MR, Ausems MGEM, van Engelen K, van de Beek I, Berger LPV, van Asperen CJ, Gomez Garcia EB, Maas AHEM, Hooning MJ, van der Wall E, van Leeuwen FE, Schagen SB. Terra L, et al. Among authors: van dorst ebl. BJOG. 2023 Jul;130(8):968-977. doi: 10.1111/1471-0528.17415. Epub 2023 Feb 19. BJOG. 2023. PMID: 36715559
Case-mix adjustment to compare hospital performances regarding complications after cytoreductive surgery for ovarian cancer: a nationwide population-based study.
Algera MD, Baldewpersad Tewarie NMS, Driel WJV, van Ham MAPC, Slangen BFM, Kruitwagen RFPM, Wouters MWJM; Participants of the Dutch Gynecological Oncology Audit Collaborator Group. Algera MD, et al. Int J Gynecol Cancer. 2023 Apr 3;33(4):534-542. doi: 10.1136/ijgc-2022-003981. Int J Gynecol Cancer. 2023. PMID: 36581486
Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy.
Terra L, Beekman MJ, Engelhardt EG, Heemskerk-Gerritsen BAM, van Beurden M, Roeters van Lennep JE, van Doorn HC, de Hullu JA, Van Dorst EBL, Mom CH, Slangen BFM, Gaarenstroom KN, van der Kolk LE, Collée JM, Wevers MR, Ausems MGEM, Van Engelen K, van de Beek I, Berger LPV, van Asperen CJ, Gomez Garcia EB, Maas AHEM, Hooning MJ, Aaronson NK, Mourits MJE, van Leeuwen FE. Terra L, et al. Among authors: van dorst ebl. Am J Obstet Gynecol. 2023 Apr;228(4):440.e1-440.e20. doi: 10.1016/j.ajog.2022.11.1289. Epub 2022 Nov 17. Am J Obstet Gynecol. 2023. PMID: 36403862 Free article.
Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe.
Van der Kolk WL, Van der Zee AGJ, Slomovitz BM, Baldwin PJW, Van Doorn HC, De Hullu JA, Van der Velden J, Gaarenstroom KN, Slangen BFM, Kjolhede P, Brännström M, Vergote I, Holland CM, Coleman R, Van Dorst EBL, Van Driel WJ, Nunns D, Widschwendter M, Nugent D, DiSilvestro PA, Mannel RS, Tjiong MY, Boll D, Cibula D, Covens A, Provencher D, Runnebaum IB, Monk BJ, Zanagnolo V, Tamussino K, Oonk MHM; all GROINSS-V I and II participants. Van der Kolk WL, et al. Among authors: van dorst ebl. Gynecol Oncol. 2022 Oct;167(1):3-10. doi: 10.1016/j.ygyno.2022.07.017. Epub 2022 Sep 7. Gynecol Oncol. 2022. PMID: 36085090 Free article.
Mainstream germline genetic testing for patients with epithelial ovarian cancer leads to higher testing rates and a reduction in genetics-related healthcare costs from a healthcare payer perspective.
Bokkers K, Frederix GWJ, Velthuizen ME, van der Aa M, Gerestein CG, van Dorst EBL, Lange JG, Louwers JA, Koole W, Zweemer RP, Ausems MGEM. Bokkers K, et al. Among authors: van dorst ebl. Gynecol Oncol. 2022 Oct;167(1):115-122. doi: 10.1016/j.ygyno.2022.08.011. Epub 2022 Aug 26. Gynecol Oncol. 2022. PMID: 36031452 Free article.
38 results